Additionally, while we analyzed the main ApoC-III variants, we did not investigate other SNPs such as PNPLA3, TM6SF2, GCKR, MBOAT7, or HSD17B13, which are extensively recognized for their significant contributions to MASLD susceptibility and progression. This evidence concerns the gene TM6SF2 and metabolic dysfunction-associated steatotic liver disease.